(Q84517313)
Statements
Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously (English)
Wolfgang Kamin
Matthias Volkmar Kopp
Frank Erdnuess
Uwe Schauer
3 September 2009